medmix was formed as a spin-off of the fastest-growing and most profitable business unit, the Applicator Systems (APS) division of the Sulzer Group. Sulzer shareholders approved the spin-off on September 20, 2021, and medmix (SIX: MEDX) was listed on the stock exchange on September 30, 2021.

The founding of medmix created a new independent global market leader for high-precision delivery devices. Today, medmix holds a leading position in the healthcare, consumer and industrial end markets. Our customers benefit from our commitment to innovation and technological advancement, which has resulted in over 900 active patents. Our 14 production sites worldwide and our highly motivated and experienced team of nearly 2,700 employees provide our customers with uncompromising quality, proximity and flexibility.